Monitor Acne Lessions Count Reduction as Result of Usinfg the DeviceNCT01678482
Clinical and Usability Study to Determine Safety and Efficacy of the Clear Device for Acne Treatment
A study testing light based device for treatment of acne in people with Monitor Acne Lessions Count Reduction as Result of Usinfg the Device, run by Home Skinovations Ltd. at 1 site in Canada.
Trial summary
This is a clinical research study to determine the ability of the Clear device to treat mild to moderate inflammatory acne, and to determine if the average person is able to use the device properly according to the labeling as describe in the operator manual. Read more about this study
- Who is it for?
- Ages 21 to 65 yearsHealthy volunteers can take part
- Conditions the study is for
- Monitor Acne Lessions Count Reduction as Result of Usinfg the Device
- What is being tested?
- light based device for treatment of acne
- Type of treatment
- Medical device
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 50 participants
- Where
- 1 siteCanada
- Study dates
- Nov 2011to Apr 2012
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 21 to 65 years
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Presence of mild to moderate acne.
- Skin Type I to VI (Fitzpatrick).
- Males or females who are 21-65 years old.
- Willingness to follow the treatment schedule, post-treatment care and have photographs taken.
Who cannot join
- Pacemaker or internal defibrillator.
- Permanent implant in the treated area, such as metal plates and screws or silicon, unless deep enough in the bone.
- Skin areas that have been injected with Botox/ Hyaluronic acid /collagen/fat injections or other augmentation methods with bio-material during last 6 months.
- Current or history of skin cancer, or any other type of cancer, or pre-malignant moles.
- Current severe medical conditions, such as heart and lung disorders.
- Pregnant or breastfeeding.
Show all 19Show fewer
- Impaired immune system due to immunosuppressive diseases such as AIDS and HIV, or use of immunosuppressive medications.
- History of diseases stimulated by heat, such as recurrent Herpes Simplex (cold sores) in the treatment area, unless treated by following a preventive regime.
- Poorly controlled endocrine disorders, such as diabetes or thyroid disorders.
- Any active skin condition in the treatment area, such as sores, psoriasis, eczema, and rash and rosacea.
- History of skin disorders, keloids (excessive scarring), abnormal wound healing, as well as very dry and fragile skin.
- History of bleeding disorders, or use of anticoagulants in the last 10 days.
- Any facial surgery performed within 12 months prior to treatment.
- Facial dermabrasion, facial resurfacing, or deep chemical peeling within the last 3 months.
- Received treatment with light, laser, radiofrequency (RF), or other devices in the treated area within 6 months.
- Used isotretinoin (Accutane®) within 6 months prior to treatment.
- Using of non-steroidal anti-inflammatory drugs (NSAIDS, e.g., ibuprofen-containing agents) 1 week before and after each treatment session.
- Subjects that are currently or have recently been treated with Alpha-Hydroxi Acids (AHAs), Beta-Hydroxi Acids (BHAs), Retin-A®, topical retinoids or azelaic acid.
- Subjects that have been on a steroid regimen within the past 3 months.
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Clinical and Usability Study to Determine Safety and Efficacy of the Clear Device for the Treatment of Mild to Moderate Inflammatory Acne.
This is a clinical research study to determine the ability of the Clear device to treat mild to moderate inflammatory acne, and to determine if the average person is able to use the device properly according to the labeling as describe in the operator manual.
The study involve treatments twice a week over 4 weeks total of 8 treatment sessions, in which the subjects will be treating themselves with the Clear device, and 2 follow-up visits to evaluate the results. The clinical result will be assessed by the investigator for improvement in the acne condition. Treatment will be performed on the face of subjects enrolled and who meet the inclusion criteria.
Read the detailed description
The subjects will be recruited if they are eligible to participate in the study according with the device labeling presented at the doctor's office by printed ads. Subjects will be given information about the Clear device according to its labeling. After reading the information and labeling, it will be the subjects' decision if they understand the device label information and if they want to participate in the study. The investigator will review the inclusion / exclusion criteria with the subjects to ensure eligibility.
- Being tested
- light based device for treatment of acne
- Keywords
- Acne, LED, blue light
- Medical subject headings
- Acne Vulgaris
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
light based device for treatment of acneDevice
| Study group | Role | What they receive |
|---|---|---|
| lession count reduction post treatment | Experimental | * A total of 50 subjects were included.
* The majority are female (62 %)
* At baseline the average number of lesions was 20.5±7.1, ranging from 6 to 36 lesions.
* All subjects demonstrated a reduction in lesion count.
* The average improvement after one month was 56.7%±8.9%, and remained similar also after 3 months 57.7%±9.4%.
* The percent of responders (with at least 40% of reduction) was 94% after 1 month and 96% after 3 months
* The Percent of responders is similar for males \& females and similar for cheeks \& front. Receives: Device: light based device for treatment of acne |
What is being measured
The primary outcome is the main question the study is designed to answer.
Acne lession count
acne count post treatment compared to based line count
Measured: 3 months post treatment
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted5 Sep 2012 (estimated)
- Study startNov 2011
- Primary completionApr 2012
- Study completionApr 2012
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Monitor Acne Lessions Count Reduction as Result of Usinfg the DeviceStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- Single blind
- Who is masked
- Participant
- Enrolment
- 50 participants (actual)
Sponsor and investigators
- Lead sponsor
- Home Skinovations Ltd.
- Sponsor type
- Industry (pharma, biotech, devices)
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT01678482
- Sponsor's protocol ID
- C1
- Status last verified
- Aug 2012
- First submitted
- 31 Aug 2012
- Last updated
- 5 Sep 2012
- Results posted
- No
- Data monitoring committee
- No
Study at a glance
From the registry record, last updated by the sponsor on 5 Sep 2012. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Clinical and Usability Study to Determine Safety and Efficacy of the Clear Device for the Treatment of Mild to Moderate Inflammatory Acne.
- ClinicalTrials.gov ID
- NCT01678482
- Acronym / sponsor ID
- C1
- Keywords
- Acne, LED, blue light
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 50 participants (actual)
- Lead sponsor
- Home Skinovations Ltd.Industry (pharma, biotech, devices)
- Study start
- Nov 2011
- Primary completion
- Apr 2012 (actual)
- Study completion
- Apr 2012 (actual)
- First posted
- 5 Sep 2012 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This is a clinical research study to determine the ability of the Clear device to treat mild to moderate inflammatory acne, and to determine if the average person is able to use the device properly according to the labeling as describe in the operator manual.
The study involve treatments twice a week over 4 weeks total of 8 treatment sessions, in which the subjects will be treating themselves with the Clear device, and 2 follow-up visits to evaluate the results. The clinical result will be assessed by the investigator for improvement in the acne condition. Treatment will be performed on the face of subjects enrolled and who meet the inclusion criteria.
Detailed description
The subjects will be recruited if they are eligible to participate in the study according with the device labeling presented at the doctor's office by printed ads. Subjects will be given information about the Clear device according to its labeling. After reading the information and labeling, it will be the subjects' decision if they understand the device label information and if they want to participate in the study. The investigator will review the inclusion / exclusion criteria with the subjects to ensure eligibility.
Study design
- Primary purpose
- Treatment
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- Single blind (participant)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| lession count reduction post treatment | Experimental | Device: light based device for treatment of acne* A total of 50 subjects were included. * The majority are female (62 %) * At baseline the average number of lesions was 20.5±7.1, ranging from 6 to 36 lesions. * All subjects demonstrated a reduction in lesion count. * The average improvement after one month was 56.7%±8.9%, and remained similar also after 3 months 57.7%±9.4%. * The percent of responders (with at least 40% of reduction) was 94% after 1 month and 96% after 3 months * The Percent of responders is similar for males \& females and similar for cheeks \& front. |
Who may qualify
- Ages
- 21 to 65 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (4 listed)
- Presence of mild to moderate acne.
- Skin Type I to VI (Fitzpatrick).
- Males or females who are 21-65 years old.
- Willingness to follow the treatment schedule, post-treatment care and have photographs taken.
Key exclusion criteria (19 listed)
- Pacemaker or internal defibrillator.
- Permanent implant in the treated area, such as metal plates and screws or silicon, unless deep enough in the bone.
- Skin areas that have been injected with Botox/ Hyaluronic acid /collagen/fat injections or other augmentation methods with bio-material during last 6 months.
- Current or history of skin cancer, or any other type of cancer, or pre-malignant moles.
- Current severe medical conditions, such as heart and lung disorders.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| light based device for treatment of acne | Device | lession count reduction post treatment |
Primary outcome
Acne lession count
Time frame: 3 months post treatment
acne count post treatment compared to based line count
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 5 Sep 2012.
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing light based device for treatment of acne in people with Monitor Acne Lessions Count Reduction as Result of Usinfg the Device, run by Home Skinovations Ltd. at 1 site in Canada.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 19 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 5 Sep 2012. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Acne lession count (time frame: 3 months post treatment). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Sep 2012.